Metraipolis › archive › dc_3e6c91bb5281

Analysis of adverse drug reactions in 507 cases of Tislelizumab: A real-world retrospective study based on data from Guangxi, China — Europe PMC PMID:40811627

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40811627
DOI
10.1371/journal.pone.0329464
License (as archived)
solo-consultazione
Archived
2026-11-10T15:44:01.036Z
SHA-256 of the archived text
db21ff2da544d153e5cc44140a4217cd054c85e2bf158014670fdd8216cacaa3
Stable URL of this page
https://metraipolis.com/documento/dc_3e6c91bb5281

How to cite

Analysis of adverse drug reactions in 507 cases of Tislelizumab: A real-world retrospective study based on data from Guangxi, China — Europe PMC PMID:40811627 — Europe PMC (en), https://europepmc.org/article/MED/40811627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e6c91bb5281 (Metraipolis archive dc_3e6c91bb5281, sha256 db21ff2da544d153e5cc44140a4217cd054c85e2bf158014670fdd8216cacaa3)
BibTeX
@misc{dc3e6c91bb5281,
  title = {Analysis of adverse drug reactions in 507 cases of Tislelizumab: A real-world retrospective study based on data from Guangxi, China — Europe PMC PMID:40811627},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40811627},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e6c91bb5281; sha256 db21ff2da544d153e5cc44140a4217cd054c85e2bf158014670fdd8216cacaa3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40811627. Agents can read the archived copy with the MCP tool read_document.